BYAH is trading at $1.08 (6.1% down) as traders continue to react to heightened volatility following Park Ha Biological Technology’s recent $2.0 million registered direct offering.
- The stock has experienced sharp swings and profit-taking since the deal closed, with today's move appearing to be an extension of those post-offering dynamics.
- There are no fresh company-specific headlines this morning to account for the pre-market drop.
- The downward movement occurs despite a generally positive sentiment in the broader market.